Moneycontrol
Nov 13, 2017 12:02 PM IST | Source: Moneycontrol.com

Suven Life sciences presenting at Neuroscience 2017 at Washington DC

Suven Life Sciences is participating and presenting positive Pre-clinical and Phase-1 clinical data of several advanced molecules from their portfolio of new chemical entities (NCEs) and the status of Phase 2 clinical trial of their lead compound SUVN-502 at Neuroscience 2017, organized by Society for Neuroscience being held at Washington DC, USA during 13-15 November 2017.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More
Suven Life Sciences is participating and presenting positive Pre-clinical and Phase-1 clinical data of several advanced molecules from their portfolio of new chemical entities (NCEs) and the status of Phase 2 clinical trial of their lead compound SUVN-502 at Neuroscience 2017, organized by Society for Neuroscience being held at Washington DC, USA during 13-15 November 2017. Source : BSE
Sections
Follow us on
Available On